跳至主要内容
临床试验/JPRN-jRCT1061230098
JPRN-jRCT1061230098招募中Unknown

Investigation of Treatment Efficacy Prediction Method for Liver Cancer Using Circulating Tumor Cells (CTC) - PRECISE-HCC: Predicting Response of Efficacy in Circulating Tumor Cells to Immuno-Checkpoint Inhibitor in Hepatocellular Carcinoma

Sugihara Takaaki0 个研究点目标入组 20 人开始时间: 2024年2月7日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Select patients who meet all of the following criteria:
  • 1) Diagnosed with hepatocellular carcinoma by imaging or histological examination.
  • 2) Patients scheduled to receive treatment with immune checkpoint inhibitors.
  • 3) Men and women aged 20 or older when obtaining consent.

排除标准

  • Patients meeting any of the following criteria will not be included in this clinical study:
  • 1) Patients with tumors originating from other organs.
  • 2) Others deemed unsuitable as patients by the principal investigator for this study.

研究者

发起方
Sugihara Takaaki

相似试验